Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

“Arcturus is actively engaged with the U.S. government to prepare for the next pandemic, and clearance to proceed into the clinic with our STARR self-amplifying mRNA ... potential vaccine to protect ...

Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.

France raises bird flu risk to high as EU cases increase ... by approving Moderna's RSV vaccine for adults aged 60 and over, ...

Avian flu is still present in Canada ... Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, available next year. A move by ...

Recent health news highlights include Recordati's nonchalance towards potential U.S. tariffs, Canada's approval of Moderna's ...

Experts in public health, vaccines, and other health and biology-related fields are concerned about what the next Trump ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

H5N1 Virus Isolated from Infected Dairy Worker Is 100% Lethal in Ferrets, but Does Not Appear to Be Circulating in Nature Anymore Oct. 28, 2024 — A strain of H5N1 avian influenza virus found in ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory ... along with a seasonal influenza candidate also in phase 2 and one for avian influenza in phase ...

A man in Mexico has died in what the World Health Organization (WHO) has said is the first lab-confirmed human infection with the H5N2 strain of bird ... vaccines in clinical development ...